Codes ATC:
L02BA01
Indication
Other specified malignant neoplasms of breast
Code ICD11:
2D1Y
INN
Tamoxifen
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
Formulations
Oral > Solid:
10 mg (as citrate) ;
20 mg (as citrate)
Historique des statuts LME
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for tamoxifen on the complementary list of the EML for use in treatment protocols for hormone-receptor positive metastatic breast cancer was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for metastatic breast cancer is attached.